Company page

Ardelyx, Inc.

Ardelyx, Inc. is a public company traded on the American stock market under the ticker ARDX. With a market capitalization of approximately $1.24 billion, Ardelyx focuses on developing innovative therapies for gastrointestinal and renal diseases. The company is committed to advancing its pipeline to address unmet medical needs in these areas.